Theravance Biopharma, Inc. (TBPH)
14.82
+0.07
(+0.47%)
USD |
NASDAQ |
Mar 24, 13:33
Theravance Biopharma EPS Diluted (Quarterly) : 1.150 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integer Holdings Corp. | 1.383 |
| QuidelOrtho Corp. | -1.922 |
| Viatris, Inc. | -0.2951 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Nektar Therapeutics | -1.778 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 61.02M |
| Revenue (Quarterly) | 45.89M |
| Total Expenses (Quarterly) | -15.13M |
| Enterprise Value | 513.40M |
| Gross Profit Margin (Quarterly) | 96.72% |
| Earnings Yield | 13.68% |
| Normalized Earnings Yield | 13.68 |